1Buzdar AU,Guastalla JP,Nabholtz J,et al.Impact of chemotherapy regimens prior to endocrine therapy[J].Cancer, 2006,107(3):472-480.
2HillnerB E,IngleJ N,ChlebowskiR J,et al.American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer[J].Clin Oncol, 2003,21:4042-4057.
3Brufsky A,Harker WG,Beck JT,et al.Zoledronic acid inhibits adjuvant letrozole -induced bnoe loss in post- menopausal women with early breast cancer [J].Clin Oncol, 2007,25 (7):829.
4De Boer R,Eidtmann H,Lluch A,et al.The Z0-FAST trial: zoledronic acid effectively inhibits aromatase inhibitor associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole:24 month BMD results[J]. Breast Cancer Res Treat,2007,106(Suppl.1):S36.
